Medical Marijuana, Inc. and Subsidiary Phyto Animal Health Featured in Top Veterinary Trade Publication

Leading Veterinary Experts Endorse Company’s Lab Testing Procedures and Certificates of Analysis as the Standard for the Industry

SAN DIEGO, March 20, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary Phyto Animal Health has garnered news coverage in a top veterinary trade publication, American Veterinarian.

A March 13, 2018, article on the American Veterinarian website entitled “Phyto Animal Health’s Line of CBD Pet Products,” features interviews with executive members of the  Phyto Animal Health Veterinary Advisory Board, Liz Hughston, MEd., RVT, CVT, VTS (SAIM, ECC), and Stephen F. Cital, RVT, SRA, RLAT, VTS-Lab Animal.

The article, which includes a video interview, outlines how Phyto Animal Health products are made of the highest quality cannabidiol (CBD) hemp oil products available on the market because of the Company’s laboratory testing procedures – which ensure that the products are pure and have a wide variety of terpenoids and flavonoids. These qualities are important because they make the products palatable and provide a full-spectrum of benefits.

“We want all of our subsidiaries to be known as leaders in their respective product markets and are pleased to see these veterinary experts endorsing Phyto Animal Health in this nationally recognized publication,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus.

In the article, Stephen Cital talks about the Company’s Certificates of Analysis (COAs) saying, “What’s nice about Phyto Animal Health compared to some of the other companies out there is they is they have a Certificate of Analysis of the cannabinoids that are in the product but also have other elemental analyses which are important because if we’re getting these products from overseas we could have high levels of lead and other elements that could be very toxic.”

“We have sworn a Pledge of Loyalty to Good Manufacturing practices and our Triple Lab Testing® process allows pet owners to place trust in our products,” said Phyto Animal Health CEO Ian Quinn. “Our goal is to continue to provide the most up-to-date, scientifically-based approach to pet health in all that we do and provide transparency on the quality and safety of our products.”

About Phyto Animal Health

As a company that cares about the health and wellbeing of all animals, Phyto Animal Health also cares about the earth. Using the least amount of water and other resources to create its products, the Company aims to leave the smallest footprint possible while helping provide cats, dogs and horses with the nutrients they need to have outstanding mental and physical health.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Public Relations Contact:

Andrew Hard

Chief Executive Officer CMW Media

P. 858-264-6600

[email protected]